Folate receptor alpha autoantibodies in the serum of patients with relapsing-remitting multiple sclerosis (RRMS)

Clin Neurol Neurosurg. 2024 Feb:237:108161. doi: 10.1016/j.clineuro.2024.108161. Epub 2024 Feb 3.

Abstract

Objective: Multiple sclerosis (MS) is a potentially progressive, autoimmune neurologic disorder of the central nervous system (CNS), resulting from an autoimmune attack on central nervous system white matter. Folate deficiencies are linked to DNA instability and breakdown of phospholipid membranes and thus might affect myelin integrity. Folic acid exerts its effects through its receptors (FRs). Folate receptor alpha autoantibodies (FRAA) can block folate transport to the brain. Due to important role of folate in the pathogenesis of MS, in this project we aimed to study FRAA serum levels in patients with relapsing remitting multiple sclerosis (RRMS).

Methods: Fifty-four patients with RRMS and 58 healthy individuals were enrolled in this study. Serum samples were collected from all participants and folate receptor alpha autoantibody (FRAA) serum concentration was measured by Enzyme-linked immunosorbent assay (ELISA).

Results: The results showed that FRAA serum levels in patients with RRMS is 67.20 ± 19.79 ng/ml as compared to controls which was 37.32 ± 13.26 ng/ml. Significant increase in folate receptor autoantibody serum concentration was seen in patients with RRMS when compared to control group (P = 0.007). The results showed that a high concentration of folate receptor autoantibody is associated with RRMS. We have also found that 85.18% (46/54) of patients with RRMS were positive for serum FRAA, whereas the prevalence in controls was only 46.55% (27/58).

Conclusions: It is concluded that serum FRAA are more prevalent in RRMS patients than controls. The findings also suggest that FRAA might be involved in the pathophysiology of RRMS.

Keywords: Autoantibodies; Enzyme-Linked Immunosorbent Assay; Folate Receptor 1; Relapsing-Remitting Multiple Sclerosis.

MeSH terms

  • Autoantibodies
  • Folate Receptor 1
  • Folic Acid
  • Humans
  • Multiple Sclerosis*
  • Multiple Sclerosis, Relapsing-Remitting*

Substances

  • Folate Receptor 1
  • Autoantibodies
  • Folic Acid